Lung cancer: Chemotherapy drug pemetrexed shows promising results for patients with ALK-positive lung cancer, study suggests

Monday, March 7, 2011 - 22:30 in Health & Medicine

A discovery shows testing lung cancer on a molecular level can produce new insights into this deadly disease. People with ALK-positive lung cancer have much better outcomes with an established chemotherapy drug called pemetrexed (trade name: Alimta), new study suggests.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net